CIK 0001678660
- Non-accelerated filer
- Smaller reporting company
Prelude Therapeutics Inc
Sign in to watch- Ticker
- PRLD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811384762
- Phone
- +1 302-467-1280
- Business address
- 175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
- Former names
- Prelude Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-29 | ORBIMED ADVISORS LLC Director | Conversion · Series C Preferred Stock | −619,850 | 0 | ||
| 2020-09-29 | ORBIMED ADVISORS LLC Director | Conversion · Series C Preferred Stock | −413,234 | 0 | ||
| 2020-09-29 | ORBIMED ADVISORS LLC Director | Conversion · Non-Voting Common Stock | +5,555,186 | 5,555,186 | ||
| 2020-09-29 | Dier Mardi Director | Purchase | +10,000 | $19.00 | $190K | 10,000 |
| 2020-09-29 | Morosini Deborah EVP, Chief of Clinical Affairs | Purchase | +444 | $19.00 | $8K | 444 |
| 2020-09-29 | Pierce Christopher EVP and Chief of Business Oper | Purchase | +3,750 | $19.00 | $71K | 3,750 |
| 2020-09-29 | Vaddi Krishna President, CEO | Conversion | +101,477 | 101,477 | ||
| 2020-09-29 | Vaddi Krishna President, CEO | Conversion | +32,876 | 551,776 | ||
| 2020-09-29 | Vaddi Krishna President, CEO | Conversion | +32,876 | 551,774 | ||
| 2020-09-29 | Vaddi Krishna President, CEO | Conversion · Series A Preferred Stock | −101,477 | 0 | ||
| 2020-09-29 | Vaddi Krishna President, CEO | Conversion · Series A Preferred Stock | −32,876 | 0 | ||
| 2020-09-29 | Vaddi Krishna President, CEO | Conversion · Series A Preferred Stock | −32,876 | 0 | ||
| 2020-09-25 | Bonita David P Director | Purchase | +526,300 | $19.00 | $10.0M | 526,300 |
| 2020-09-25 | Bonita David P Director | Purchase | +710,500 | $19.00 | $13.5M | 917,412 |
| 2020-09-25 | ORBIMED ADVISORS LLC Director | Purchase | +526,300 | $19.00 | $10.0M | 526,300 |
| 2020-09-25 | ORBIMED ADVISORS LLC Director | Purchase | +710,500 | $19.00 | $13.5M | 917,412 |
| 2020-09-24 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy) | +46,688 | 46,688 | ||
| 2020-09-24 | Bonita David P Director | Grant or award · Director Stock Option (right to buy) | +46,688 | 46,688 | ||
| 2020-09-24 | Sandor Victor Director | Grant or award · Director Stock Option (right to buy) | +3,458 | 3,458 | ||
| 2020-09-24 | Dier Mardi Director | Grant or award · Director Stock Option (right to buy) | +3,458 | 3,458 |
Page 18 of 19 · 369 trades